STEM Relative Valuation
STEM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STEM is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for STEM's competitors is 0.60, providing a benchmark for relative valuation. Stem Inc Corp (STEM) exhibits a P/S ratio of 0.54, which is -9.70% above the industry average. Given its robust revenue growth of 27.65%, this premium appears sustainable.
People Also Watch
GOOGL
Alphabet Inc
166.190
USD
+1.36%
TSLA
Tesla Inc
349.980
USD
+2.09%
META
Meta Platforms Inc
640.340
USD
-0.55%
DLHC
DLH Holdings Corp
5.010
USD
+4.81%
MAMO
Massimo Group
2.220
USD
-4.52%
EPRX
Eupraxia Pharmaceuticals Inc
3.840
USD
+1.05%
SRBK
SR Bancorp Inc
13.180
USD
0.00%
GOOG
Alphabet Inc
167.430
USD
+1.23%
NKLA
Nikola Corp
0.183
USD
-40.44%
PCSC
Perceptive Capital Solutions Corp
10.380
USD
+0.10%
FAQ
Is Stem Inc (STEM) currently overvalued or undervalued?
Stem Inc (STEM) is now in the Overvalued zone, suggesting that its current forward PS ratio of 0.54 is considered Overvalued compared with the five-year average of 4.17. The fair price of Stem Inc (STEM) is between 0.31 to 0.53 according to relative valuation methord. Compared to the current price of 0.54 USD , Stem Inc is Overvalued By 2.18% .
What is Stem Inc (STEM) fair value?
How does STEM's valuation metrics compare to the industry average?
What is the current P/B ratio for Stem Inc (STEM) as of May 19 2025?
What is the current FCF Yield for Stem Inc (STEM) as of May 19 2025?
What is the current Forward P/E ratio for Stem Inc (STEM) as of May 19 2025?